EVAXION BIOTECH A/S (EVAX)

US29970R2040 - ADR

3  0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

EVAXION BIOTECH A/S

NASDAQ:EVAX (3/28/2024, 9:30:21 AM)

3

0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap14.43M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

EVAX Daily chart

Company Profile

Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Company Info

EVAXION BIOTECH A/S

Bredgade 34E, Copenhagen K

COPENHAGEN 1260

CEO: Lars Staal Webner

Employees: 63

Website: https://www.evaxion-biotech.com/

EVAX News

News Image20 hours ago - InvestorPlaceEVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023

EVAX stock results show that Evaxion Biotech met analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea day ago - Evaxion BiotechEvaxion Announces Business Update and Full Year 2023 Financial Results
News Imagea day ago - Evaxion BiotechEvaxion Announces Business Update and Full Year 2023 Financial Results

COPENHAGEN, Denmark, March 27, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today provides a business update and announces full year 2023 financial results.

News Image8 days ago - Evaxion BiotechEvaxion organise la journée de la recherche et développement et dévoile le vaste potentiel de sa plateforme AI-Immunology™

La plateforme AI-Immunology™ brevetée ouvre la voie d'une nouvelle ère dans le monde de la découverte, de la conception et du développement de vaccins...

News Image8 days ago - Evaxion BiotechEvaxion veranstaltet F&E-Tag und stellt das breite Potenzial seiner AI-Immunology™-Plattform vor

Die unternehmenseigene AI-Immunology™-Plattform bietet das Potenzial für eine neue Ära der Entdeckung, des Designs und der Entwicklung von Impfstoffen...

News Image9 days ago - Evaxion BiotechEvaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

EVAX Twits

Here you can normally see the latest stock twits on EVAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example